Filing metadata

Accession number
0001562180-22-005389
Form type
Form 3
Filer
G1 Therapeutics, Inc.
CIK
CIK 1560241
Filed
Jun 29, 2022
Reporting period
Jun 27, 2022
Description
Initial ownership

Explore SEC Filings Hub